Clinical Trials Logo

Filter by:
  • Not yet recruiting  
  • « Prev · Page [327]
NCT ID: NCT00201630 Not yet recruiting - Prostate Cancer Clinical Trials

Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy

Start date: September 2005
Phase: Phase 3
Study type: Interventional

To asess the efficacy of Uroxatrol, an alpha blocker in men undergoing prostate brachytherapy to treat prostate cancer, and whether the use of Uroxatrol in advance of the brachytherapy is better or not than starting it on the day of surgery.

NCT ID: NCT00067977 Not yet recruiting - Clinical trials for Kidney, Polycystic, Autosomal Dominant

Clinical Trial to Slow the Progression of ADPKD

Start date: n/a
Phase: N/A
Study type: Interventional

This study will determine whether certain blood pressure medications will slow cyst growth or keep kidneys functioning longer in patients with autosomal dominant polycystic kidney disease (ADPKD). The study will take place at several sites in the United States. The start date of the study has not yet been determined.

NCT ID: NCT00062530 Not yet recruiting - HIV Infections Clinical Trials

Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers

Start date: n/a
Phase: Phase 1
Study type: Interventional

This study will test the safety of and immune response to an oral HIV vaccine in healthy volunteers. The vaccine in this study uses a weakened bacterium called Salmonella typhi to deliver an HIV gene into the body through the mouth. The body then produces an HIV protein from the gene; this protein stimulates an anti-HIV immune response. The vaccine contains only one of the many substances that HIV needs to make more copies of itself, so the vaccine itself cannot cause HIV or AIDS.

NCT ID: NCT00050765 Not yet recruiting - Clinical trials for Coronary Artery Disease

Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection

Start date: August 2006
Phase: Phase 1
Study type: Interventional

MyoCellâ„¢ implantation by epicardial injection during CABG surgery has the potential to add a new dimension to the management of post-infarct deterioration of cardiac function. Based on existing non-clinical studies and clinical reports, implantation of autologous skeletal myoblasts appears to lead to the replacement of non-functioning myocardial scar with functioning muscle and appears to improve myocardial performance relative to case without myoblast implantation. In a few investigational patients, myoblast implantation can be, and has been, done in conjunction with CABG and appears to have the potential to provide for additive treatment during surgery. The present study is being conducted to evaluate more fully the safety of MyoCellâ„¢ implantation via epicardial injection during CABG surgery and its effect on regional myocardial function.